Richard E. Nelson, PhD

Research Interests

  • Health Economics
  • Infectious Disease
  • Rural Health
  • Health Services Research
  • Vulnerable Populations
  • Homeless Persons


  • English
  • Portuguese

Academic Information

  • Departments: Internal Medicine - Research Associate Professor, Pediatrics - Adjunct Assistant Professor
  • Divisions: Epidemiology, Pediatric Administration

Academic Office Information

  • 801-582-1565
  • Williams Building
    Clinical Epidemiology
    295 Chipeta Way
    Salt Lake City, UT 84108

Education History

Type School Degree
Graduate Training University of Utah
Clinical Investigation
Doctoral Training University of Virginia
Graduate Training University of Virginia
Undergraduate Westminster College
Mathematics and Economics

Selected Publications

Journal Article

  1. Jones BE, Ying J, Stevens V, Haroldsen C, He T, Nevers M, Christensen MA, Nelson RE, Stoddard GJ, Sauer BC, Yarbrough PM, Jones MM, Goetz MB, Greene T, Samore MH (2020). Empirical Anti-MRSA vs Standard Antibiotic Therapy and Risk of 30-Day Mortality in Patients Hospitalized for Pneumonia. (Epub ahead of print) JAMA Intern Med.
  2. Jalali A, Martin C, Nelson RE, Vanneman ME, Martin BI, Cooney KA, Waitzman NJ, ONeil B (2019). Provider Practice Competition and Adoption of Medicare's Oncology Care Model. Med Care, 58(2), 154-160.
  3. Stevens VW, Shoemaker HE, Jones MM, Jones BE, Nelson RE, Khader K, Samore MH, Rubin MA (2020). Validation of the SHEA/IDSA severity criteria to predict poor outcomes among inpatients and outpatients with Clostridioides difficile infection. Infect Control Hosp Epidemiol, 1-7.
  4. Albin SR, Bellows BK, Van Boerum DH, Hunter S, Koppenhaver SL, Nelson RE, Marcus R, Dibble L, Cornwall M, Fritz JM (2020). Cost-Effectiveness of Operative versus Non-Operative Management of Patients with Intra-Articular Calcaneal Fractures. (Epub ahead of print) J Orthop Trauma.
  5. Marra AR, Perencevich EN, Nelson RE, Samore M, Khader K, Chiang HY, Chorazy ML, Herwaldt LA, Diekema DJ, Kuxhausen MF, Blevins A, Ward MA, McDanel JS, Nair R, Balkenende E, Schweizer ML (2020). Incidence and Outcomes Associated With Clostridium difficile Infections: A Systematic Review and Meta-analysis. JAMA Netw Open, 3(1), e1917597.
  6. Uffmann WJ, Christensen GV, Yoo M, Nelson RE, Greis PE, Burks RT, Tashjian RZ, Chalmers PN (2019). A Cost-Minimization Analysis of Intraoperative Costs in Arthroscopic Bankart Repair, Open Latarjet, and Distal Tibial Allograft. Orthop J Sports Med, 7(11), 2325967119882001.
  7. Goldstein KM, Fisher DA, Wu RR, Orlando LA, Coffman CJ, Grubber JM, Rakhra-Burris T, Wang V, Scheuner MT, Sperber N, Datta SK, Nelson RE, Strawbridge E, Provenzale D, Hauser ER, Voils CI (2019). An electronic family health history tool to identify and manage patients at increased risk for colorectal cancer: protocol for a randomized controlled trial. Trials, 20(1), 576.
  8. Stevens VW, Khader K, Echevarria K, Nelson RE, Zhang Y, Jones M, Timbrook TT, Samore MH, Rubin MA (2019). Use of oral vancomycin for Clostridioides difficile Infection (CDI) and the risk of vancomycin-resistant Enterococci (VRE). (Epub ahead of print) Clin Infect Dis.
  9. Makarewich CA, Stotts AK, Yoo M, Nelson RE, Rothberg DL (2019). Inpatient Versus Outpatient Treatment of Gartland Type II Supracondylar Humerus Fractures: A Cost and Safety Comparison. (Epub ahead of print) J Pediatr Orthop.
  10. Nelson RE, Ma J, Miller K, Lawrence P, LaFleur J, Grotzke M, Barker A, Cannon GW, Battistone MJ (2019). The impact of a musculoskeletal training program on residents' recognition and treatment of osteoporosis. BMC Med Educ, 19(1), 223.
  11. Nelson SD, Nelson RE, Cannon GW, Lawrence P, Battistone MJ, Grotzke M, Rosenblum Y, LaFleur J (2014). Cost-effectiveness of training rural providers to identify and treat patients at risk for fragility fractures. Osteoporos Int, 25(12), 2701-7.
  12. Nelson RE, Hoop R, Korner E, DuVall S, Hayden CL, Knippenberg K, Morgan T, Pandya P, Han J, LaFleur J (2014). Predicting Discontinuation of Pegylated Interferon as a Result of Lack of Efficacy in United States Veterans With Chronic Hepatitis C on Dual Therapy. Ann Pharmacother, 48(7), 826-836.
  13. LaFleur J, Hoop R, Morgan T, DuVall SL, Pandya P, Korner E, Knippenberg K, Hayden C, Nelson RE (2014). High rates of early treatment discontinuation in hepatitis C-infected US veterans. BMC Res Notes, 7, 266.
  14. Nelson RE, Battistone MJ, Ashworth WD, Barker AM, Grotzke M, Huhtala TA, Lafleur J, Tashjian RZ, Cannon GW (2014). Cost effectiveness of training rural providers to perform joint injections. Arthritis Care Res (Hoboken), 66(4), 559-66.
  15. Nelson RE, Nelson SL, Huttner B, Gundlapalli A (2014). The effect of Medicare Part D on health care utilization for non-elderly Medicare recipients with disabilities. Disabil Health J, 7(1), 64-9.
  16. Nelson RE, Nebeker JR, Hayden C, Reimer L, Kone K, LaFleur J (2013). Comparing adherence to two different HIV antiretroviral regimens: an instrumental variable analysis. AIDS Behav, 17(1), 160-7.
  17. Nelson RE, Nebeker JR, Sauer BC, LaFleur J (2012). Factors associated with screening or treatment initiation among male United States veterans at risk for osteoporosis fracture. Bone, 50(4), 983-8.
  18. LaFleur J, Nelson RE, Yao Y, Adler RA, Nebeker JR (2012). Validated risk rule using computerized data to identify males at high risk for fracture. Osteoporos Int, 23(3), 1017-27.
  19. LaFleur J, Nelson RE, Sauer BC, Nebeker JR (2011). Overestimation of the effects of adherence on outcomes: a case study in healthy user bias and hypertension. Heart, 97(22), 1862-9.
  20. Nelson RE, McAdam-Marx C, Evans ML, Ward R, Campbell B, Brixner D, Lafleur J (2011). Patent extension policy for paediatric indications: an evaluation of the impact within three drug classes in a state Medicaid programme. Appl Health Econ Health Policy, 9(3), 171-81.
  21. Nelson RE, Samore MH, Smith KJ, Harbarth S, Rubin MA (2010). Cost-effectiveness of adding decolonization to a surveillance strategy of screening and isolation for methicillin-resistant Staphylococcus aureus carriers. Clin Microbiol Infect, 16(12), 1740-6.
  22. Nelson RE, Samore M, Smith KJ, Harbarth S, Rubin M (2010). Cost-Effectiveness of Adding Decolonization to a Surveillance Strategy of Screening and Isolation for MRSA Carriers. Clin Microbiol Infect, 16(8), 1427-1436.


  1. LaFleur J, Nelson RE, Hoop R, Morgan T, Pandya P, Nelson SD, Hamzeh F (2011). Many United States veterans with chronic hepatitis-C discontinue pegylated interferon therapy for reasons other than non-response. [Abstract]. Hepatology, 54(4), 799a.
  2. Shen S, South BR, Palmer M, DuVall SL, Nelson R, Samore M, Gundlapalli AV (2/15/2011). Classifying Features from VA Clinical Documents to Identify Homeless or At-Risk Veterans [Abstract]. VA HSR&D Annual Meeting 2011.
  3. Shuying Shen, Brett R South, Miland Palmer, Scott Duvall, Richard Nelson, Matthew Samore, Adi V Gundlapalli (2010). Classifying Features from VA Clinical Documents to Identify Homeless or At-Risk Veterans [Abstract]. International Society for Disease Surveillance.

U of U Health News